XSC
EW icon

X-Square Capital’s Edwards Lifesciences EW Stock Holding History

X-Square Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,193
Closed -$209K – 152
2022
Q2 		$209K Hold
2,193
– – 0.13% 133
2022
Q1 		$258K Buy
2,193
+1
+0% +$112 0.13% 130
2021
Q4 		$284K Hold
2,192
– – 0.14% 127
2021
Q3 		$248K Buy
+2,192
New +$250K 0.13% 131

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

X-Square Capital's EW Position: Q3 2022 in Review

X-Square Capital sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 2,193 shares — an estimated $209K sold.

X-Square Capital first reported a position in EW in Q3 2021 and held it in 4 quarters. The position peaked at $284K in Q4 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • X-Square Capital reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • X-Square Capital sold 2,193 Edwards Lifesciences shares in Q3 2022, an estimated $209K.
  • X-Square Capital first reported a position in Edwards Lifesciences in Q3 2021 and held it in 4 quarters.
  • X-Square Capital's Edwards Lifesciences position peaked at $284K in Q4 2021.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on X-Square Capital's 13F filing for Q3 2022, filed 4 Nov 2022.